PHARMA
Quintiles, Prodia To Collaborate On Diabetes Study In Indonesia
Quintiles today announced the start of its first global diabetes study involving Indonesia, through a partnership with Prodia Clinical Laboratory for in-country testing of samples.
Clinical Trial To Test If Vitamin D Can Prevent Multiple Sclerosis
A new clinical trial set to take place in Australia and New Zealand will test whether vitamin D can prevent multiple sclerosis in those at risk of developing the disease.
WHO Prequalifies Indian Malaria Drug
A new artemisinin-based malaria drug produced by Indian pharmaceutical company Cipla has been prequalified by the World Health Organization (WHO).
Fab’entech Launches H5N1 Phase I Trial In Singapore
French biotech Fab'entech has launched a Phase I clinical trial in Singapore for its product against the H5N1 Avian Influenza virus.
Takeda To Acquire Vaccine Maker LigoCyte Pharma For US$60m
Takeda Pharma will acquire LigoCyte Pharmaceuticals for an upfront payment of US$60 million, it announced on Friday.
Lotriga 2g Receives NDA Approval In Japan For Hyperlipidemia
The Japanese Ministry of Health, Labor and Welfare has approved a New Drug Application of Lotriga granular capsule 2g for the treatment of hyperlipidemia in Japan.
India’s Patent Laws Threaten Public Health, U.K. Experts
Pending cases against India's patent laws threaten public health and misinterpret international IP agreements, say two public health experts from the U.K.
Intercell Launches Japanese Encephalitis Vaccine In India
Austrian vaccine maker Intercell AG announced this week the launch of its Japanese Encephalitis vaccine in India.
Sanofi Pasteur’s Dengue Vaccine Shows Proof Of Efficacy: Study
The results of the world’s first dengue vaccine efficacy study confirm the safety of Sanofi Pasteur’s dengue vaccine against 3 out of 4 dengue virus serotypes.
